5

Anus Laboratories

532981 BSE

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Stock is trading at 0.04 times its book value

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 8.50% over last 3 years.
  • Dividend payout has been low at 3.80% of profits over last 3 years
  • Company's cost of borrowing seems high

Growth Rate

Revenue Growth
-2% lower than 3Y
Net Income Growth
-76% lower than 3Y

Quarterly Results

Particulars Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales
187
255
98
18
82
14
188
8
167
9
32
18
459
Expenses
198
283
141
53
121
68
230
55
193
64
87
70
429
Operating Profit
-11
-27
-43
-35
-39
-54
-42
-48
-25
-55
-55
-52
30
OPM %
-6%
-11%
-44%
-196%
-48%
-379%
-22%
-627%
-15%
-597%
-172%
-299%
6%
Other Income
51
38
37
8
82
119
55
45
28
149
107
112
107
Interest
3
3
4
0
0
3
6
7
4
2
4
2
2
Depreciation
3
3
3
3
4
4
4
4
4
6
6
7
6
PBT
33
4
-14
-30
39
59
3
-14
-5
87
42
51
129
Tax %
-4%
86%
-69%
-36%
-28%
-22%
-314%
0%
336%
2%
-23%
6%
16%
Net Profit
34
1
-4
-19
50
71
13
-14
-22
85
51
48
109
EPS in Rs
1.56
0.02
-0.2
-0.89
2.35
3.36
0.6
-0.66
-1.05
3.99
2.4
2.25
5.1
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Sales
83
104
146
155
198
262
256
Expenses
72
81
111
120
161
216
217
Operating Profit
11
23
35
35
36
46
40
OPM %
13%
22%
24%
23%
18%
18%
15%
Other Income
1
1
3
0
2
-4
0
Interest
3
5
8
7
11
17
26
Depreciation
1
1
1
2
2
4
8
PBT
8
18
28
26
26
21
6
Tax %
26%
26%
36%
37%
19%
37%
46%
Net Profit
6
14
18
16
21
13
3
EPS in Rs
—
—
—
0.67
—
—
0.14
Div. Payout %
14%
6%
7%
12%
11%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Equity Capital
5
8
8
12
24
24
24
Reserves
7
24
43
134
137
138
141
Borrowings
18
27
41
41
81
97
131
Other Liabilities
17
22
34
38
40
33
38
Total Liabilities
48
81
126
224
282
292
334
Fixed Assets
14
21
22
27
43
94
94
CWIP
0
4
4
17
38
22
35
Investments
2
3
3
3
3
0
0
Other Assets
32
53
97
178
198
176
205
Total Assets
48
81
126
224
282
292
334
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Operating
-5
3
-7
-42
13
28
-10
Investing
-6
-13
-3
-19
-40
-23
-19
Financing
10
11
9
63
27
-4
26
Net Cash Flow
0
2
-1
2
1
2
-3
Free Cash Flow
-9
-9
-10
-61
-26
6
-29
CFO/OP
-43
14
-19
-83
60
74
-18
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Debtor Days
22
26
57
146
124
77
119
Inventory Days
165
212
231
269
206
140
135
Days Payable
91
92
63
85
72
13
12
Cash Conversion Cycle
96
145
225
330
258
204
242
Working Capital Days
72
112
163
317
281
169
206
ROCE %
—
52%
48%
25%
17%
17%
12%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Anus Laboratories insights

64 extracted metrics + investor summaries across FY06–FY26.

Log in — free

Shareholding Pattern

FIIs7.81%Promot.52.41%Public16.93%DIIs22.83%As ofDec 2025

Documents

Frequently Asked Questions about Anus Laboratories

What does Anus Laboratories Ltd do?
Anu's Laboratories Limited manufactures and supplies drug intermediates and related products for the pharmaceutical industry.
Where is Anus Laboratories Ltd (532981) listed?
Anus Laboratories Ltd trades under code 532981 on the BSE.
Which sector does Anus Laboratories Ltd belong to?
Anus Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.

Company Information

Anu's Laboratories Limited manufactures and supplies drug intermediates and related products for the pharmaceutical industry.

Website anulabs.com
Listed 2008-06-04
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532981.md for Anus Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List